Posts by Peptra Labs Research
SURMOUNT Post Hoc Analysis: What a Composite Endpoint Does and Does Not Show
A post hoc analysis of four SURMOUNT trials counts participants who reached three targets at the same time. The counting method is worth as much attention as the percentages it produces.
Anti-Obesity Medications and Ageing: What a 2026 Review Reports
A narrative review published in August 2026 maps what anti-obesity medications appear to do beyond weight loss, from cardiovascular outcomes to skin laxity, and states plainly where the evidence stops short.
GHK-Cu Skin Research: Two New 2026 Papers, and Why Their Design Differs
Two GHK-Cu papers published in 2026 report anti-inflammatory and skin findings. One comes from a cosmetics company's own R&D centre, the other from a university lab, and neither tested the peptide on its own.
FDA Peptide Compounding: Panel Backs Six of Seven Substances
An FDA advisory committee recommended six of seven peptides for the 503A bulks list at its July 2026 meeting. The votes are advisory only, and compounding stays barred until rulemaking is complete.
BPC-157 and TB-500 Tendon Healing: What a New Rat Study Reports
In a rat Achilles tendon model, the authors report that only TB-500 reached biomechanical significance, and that pairing it with BPC-157 added no measurable advantage over either peptide alone.
What a New UCLA Review Says About Six Popular Research Peptides
A scoping review published online on 11 August 2026 in The American Journal of Sports Medicine takes a systematic look at the evidence ...